The lungs of C3H/HeMg mice infected with a lethal dose of the influenza virus A/WSN (H 1N 1) contained antibody to the viral neuraminidase glycoprotein but not to the haemagglutinin (HA). When coinoculated with a life-saving amount of defective interfering (DI) WSN, lungs were found to contain both anti-neuraminidase and haemagglutination-inhibiting (HI) antibodies which peaked at 3 and 5 days postinfection (p.i.), respectively. Mice coinoculated with WSN and fl-propiolactoneinactivated DI WSN had only anti-neuraminidase antibody in the lungs. The HI activity was unusual in that there was no detectable neutralizing activity. The HI activity has been afffinity-purified by adsorption to and elution from WSN HA and consisted entirely of IgG, comprising isotypes IgGl, IgG2a and IgG2b. The antibody was specific for WSN HA, of low avidity and had disappeared from the lungs by 20 days p.i. Transfer of affinity-purified HA-specific, non-neutralizing antibody to mice 24 h before infection with WSN alone protected 60~ from death. We conclude that the antibody contributes significantly to the life-saving activity of DI WSN virus and that the ability to stimulate such antibody represents a novel property of this DI virus.
INTRODUCTION
In the course of investigating the mechanism by which mice lethally infected with influenza virus strain A/WSN were protected by defective interfering (DI) WSN, we reported that there was haemagglutination-inhibiting (HI) activity in lungs which peaked at 5 days post-infection (p.i.) (Dimmock et al., 1986) but was absent from control mice infected with fl-propiolactone (BPL)-inactivated DI virus or only with WSN. The HI activity did not neutralize infectivity. Nonetheless because HI activity correlated with protection from lethal infection by DI virus (Dimmock et al., 1986) , and promoted antibody-dependent cell cytotoxicity (ADCC) in vitro (L. McLain & N. J. Dimmock, unpublished data) it was necessary to provide proof of its identity. Here we report on the characterization of the haemagglutinin (HA)-specific activity, notably that it comprises immunoglobulins of the IgG1, IgG2a and IgG2b isotypes.
The reason why mice survive lethal influenza on administration of DI WSN is not clear; it is not apparently due to the classical interfering property of DI virus (Huang & Baltimore, 1970) as there is no overall reduction in multiplication of infectious virus or antigen production in the lungs of the DI WSN-treated group. However these animals have less lung pathology and, as influenza in the mouse is an immune-mediated disease (Hurd & Heath, 1975; Suzuki et aL, 1974; Sullivan et al., 1976; Wyde et al., 1977; Wyde & Cute, 1978) with a substantial contribution from delayed-type hypersensitivity T lymphocytes (Leung & Ada, 1980; Ada et a/., 1981 ; Liew & Russell, 1980) , we have suggested that DI WSN is directly or indirectly capable of modulating the immune responses (Dimmock et al., 1986) .
Here we have investigated the in vivo protective properties of the non-neutralizing HAspecific IgG which is uniquely found in the lungs of mice infected with WSN and DI WSN. Adoptive transfer showed that it protected the majority of otherwise lethally infected mice.
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Cells. Chick embryo fibroblast (CEF) cells were used as primary cultures (Morser et al., 1973) . Madin-Darby canine kidney (MDCK) cells were originally obtained from Flow Laboratories and grown by standard procedures.
Virus. Influenza virus A/WSN (H1N1) was plaque-purified extensively before use in these experiments in primary CEF cells using a serum-free overlay medium. Stocks of infectious (standard) virus were made by inoculating the allantoic cavity of 11-day-old chick embryos with approx. 103 p.f.u. WSN and incubating for 2 days at 33 °C. Viral HA was assayed by detecting the presence of virus in doubling dilutions with chick erythrocytes.
Defective interfering virus. DI virus was produced by inoculating approx. 109 p.f.u. WSN into the allantoic cavity of embryonated chickens' eggs and incubating overnight at 33 °C. Usually three passages were sufficient to show a decrease in p.f.u. :HA ratio from about 106 to 103. This loss of specific infectivity correlated with an increase in interference in vitro, measured by an assay which used the ability of DI virus to prevent cytopathic effects caused by standard WSN (McLain et al., 1988) . In this assay MDCK cells in microtitre trays are infected at an m.o.i, of I 0 p.f.u./cell with standard virus before being inoculated with serial dilutions of DI virus. After 30 h incubation at 37 °C, monolayers are fixed and stained with crystal violet to determine the extent of cytopathic effects. The very sharp endpoints enabled the interference titre to be interpolated as the reciprocal of the dilution of DI virus that produced 63 ~ inhibition. DI virus stocks were stored as allantoic fluid in liquid nitrogen as there were indications that interference was less stable than virus infectivity at -70 °C.
Mice. C3H/HeMg mice, originally obtained from Banting & Kingman, were bred in the University Animal Facility and used at 5 weeks of age. Both sexes proved equally susceptible to WSN and were therefore used interchangeably. Mice were inoculated intranasally with 20 ~tl of virus in pbosphate-buffered saline (PBS) after ether anaesthesia and were held at 22 °C with 12 h of light.
Before inoculation into mice, DI virus was isolated from allantoic fluid by centrifugation and resuspended in PBS at a concentration of 104 haemagglutinating units (HAU)/ml or 107 DI units (DIU)/ml. Since DI and standard influenza virus particles cannot be physically separated, infectivity was removed by ultraviolet irradiation. This is possible as infectious virus has a genome about 20-fold greater in size than DI virus; hence, infectivity is inactivated while the majority of interfering activity is retained (unpublished data). Irradiated DI virus was divided into two lots, one of which was incubated with 0.01 ~ BPL for 10 h at 4 °C (Barrett et al., 1984) to inactivate interfering activity (see Results). Residual BPL was removed by dialysis overnight against excess PBS. Mice were inoculated intranasaUy with 200 HAU DI virus or BPL-inactivated DI (BPL DI) virus 2 h before infection and simultaneously coinoculated with 200 HAU DI virus or BPL DI virus and 4 LDs0 (4000 p.f.u.) standard WSN according to the protocol of Dimmock & Kennedy (1978) .
Mice were killed at intervals (on day 1 p.i. and then on alternate days up to day 15 and on days 20 and 52) by gassing with ether. Blood was obtained from the heart, and the lungs were removed and rinsed free of blood. Lungs were stored at -70 °C and later ground with sand in a mortar and pestle. After low-speed centrifugation, the supernatant was stored in aliquots at -70 °C until required. Lung extracts were treated at pH 3 to release complexed antibody by dialysis against pH 3 buffer for 6 h at 4 °C and then overnight to restore neutrality (Dimmock et al., 1986) . Latterly, extracts were made pH 3 by direct addition of an equal volume of citrate buffer, incubated on ice for 30 min and then returned to pH 7-4 by the addition of 1/10 vol. 1 M-Tris buffer. Both methods gave identical results. Treatment of serum antibody, which had been added to lungs, at pH 3 as described here had no effect on either its neutralizing or HI properties (data not shown).
Haemagglutination inhibition antibody assay. HI assays were performed by standard methods using 4 HAU and doubling dilutions of sera or the supernatant fluids from lung extracts. One HIU is the reciprocal of the dilution reducing haemagglutination to 50~o.
A~nity purification of HI antibody. The reassortant type A influenza virus NWSn JaPN (H1N2) was made between A/NWS, which has an HA almost identical with that of WSN, and A/Japan/305/57. Virus was grown as described above and purified according to Kelly & Dimmock (1974) . Lung extract was mixed with 10 s'4 HAU for 30 min at 4 °C and virus-antibody complexes were isolated by centrifugation. Antibody was released by exposure to pH 3 for 30 min on ice and virus was pelleted after readjustment of the pH to neutrality. The supernatant contained HI but no neuraminidase inhibition (NI) activity.
As an alternative, antibody was purified by adsorption to L929 cells infected with a recombinant vaccinia virus expressing the WSN HA gene (vacc-HA; Stephens et al., 1986) . Monolayers in l 1 flat bottles were infected at an m.o.i, of 10 and harvested at 14 h when HA expression was optimal. Monolayers were washed and fixed with 0.1 ~o formaldehyde and stored at 4 °C until required. Lung extract was incubated with the fixed monolayer and attached antibody was released at pH 3. Of 6400 HIU added, 90~ was recovered. Fixed monolayers could be reused at least five times.
Purification of antibody on Protein A-Sepharose. Antibodies were adsorbed to Protein A-Sepharose (Sigma) as described by Ey et al. (1987) and Seppala et al. (1981) using a modified buffer solution containing 3 M-NaC1 and 1.5 ~l-glycine buffer pH 8-9 which permits the binding of all murine IgG subclasses including IgG3. Adsorbed antibody was eluted at pH 3.
Adoptive transfer of antibody. Antibody was inoculated intravenously into 5-week-old C3H/HeMg mice 24 h before infection with 4 LDs0 (4000 p.f.u.) WSN by the intranasal route.
RESULTS
The protocol used for the preparation of acid-treated lung extracts is shown in Fig. 1 and described in Methods. Neither DI virus nor BPL DI virus alone stimulated detectable HI or NI activity. For ease of communication, the HI and NI activities will be referred to in the remainder of this paper as antibody, although one of the aims of this work was to establish the biochemical identity of the HI component.
Antigenic specificity of lung antibody HI and NI antibodies peaked at 5 and 3 days p.i., respectively (Dimmock et al., 1986; see below) . HI antibody was strain-specific and reacted only marginally even with another H1N 1 virus: with a homologous titre of 1/320, it reacted with A/PR/8/34 (H1N1) to 1/40 and A/FPV/Rostoek/34 (H7N1) to 1/30. Lungs contained an average of approx. 80000 HIU per mouse, about 20-fold more than in serum at 5 days p.i. (see below).
Avidity of lung HI antibody
Mixtures were prepared of WSN plus 160 HIU lung HI antibody or WSN plus 160 HIU of immune mouse serum, using twofold dilutions of virus from 4 to 64 HAU and keeping the antibody concentration constant. These were incubated together for 1 h at 25 °C and then diluted in serial twofold steps in microtitre plates and kept for a further 1 h to allow dilution dissociation to take place. Chicken erythrocytes were added and the amount of haemagglutination was recorded (Table 1) . Serum antibody inhibited all HA activity up to the maximum (64 HAU) tested and there was no evidence of dissociation. However, lung antibody inhibited 4 HAU completely and 8 HAU partially but failed to show any inhibition of 16 HAU or greater. The avidity of lung antibody for HA is thus considerably lower than that of serum antibody.
Isotype of lung HI antibody
In order to determine its isotype, HI antibody was purified by adsorption to and elution from a purified H1N2 recombinant virus formed between A/NWS (H1N1) and A/Japan/305/57 (H2N2). The HA of A/NWS and that of A/WSN are virtually identical. Affinity-purified antibody was reacted in solution overnight with anti-isotype sera and centrifuged the next day to remove complexes. Supernatants were tested for HI activity and we found that this was removed by anti-~ but not anti-g or -~ sera. In Ouchterlony tests the HI antibody also reacted with anti-~: but not anti-p, or anti-a sera. Further Ouchterlony tests with antisera to IgG isotypes confirmed this identification using mouse serum as a positive control. Although this is essentially a qualitative test, IgG 1 appeared to be most abundant, followed by IgG2a and IgG2b. IgG3 was not detected even though normal mouse serum reacted strongly. As a final proof of the identity of the HI activity, we used monolayers of L929 cells infected with recombinant vaccinia virus carrying the HA gene from WSN as an affinity matrix for purifying HA-specific antibody as described in Methods. The HI activity was adsorbed to the infected monolayer and was eluted from it at pH 3. The eluate contained HI but not NI activity indicating that the adsorption was specific. It was non-neutralizing and contained IgG 1, IgG2a and IgG2b (data not shown).
Failure of lung HI antibody to react with Protein A
HI activity from lung extracts was further characterized by reacting with Protein A-Sepharose (Pharmacia). Despite every effort, the HI antibody failed to bind and all activity was recovered from the eluate. Under the conditions described in Methods control mouse monoclonal antibodies of IgG1, IgG2a, IgG2b and IgG3 isotypes all bound to the column.
Compartmentation of lung and serum antibody
Lung antibody and serum antibody from individual mice were compared for HI and neutralization activity. Whereas serum of mice inoculated with WSN and DI WSN had both HI * 160 HIU of each antibody preparation was mixed with increasing amounts of WSN HAU as shown and incubated for 1 h at 25 °C. Each mixture was then diluted in serial two-fold steps and left for t h. Chicken erythrocytes were added and the residual HA activity was recorded. and neutralizing activity, lung HI antibody from the same animals was not neutralizing. The lungs of mice inoculated with WSN and BPL DI WSN contained no HI or neutralizing activity but sera of the same mice had both activities in amounts similar to those of the other experimental group (Table 2 ). This suggests that there is compartmentation of HI antibody between the lungs and serum and that there is little flow of this antibody from serum to the lungs in either infected group. The same was true of the situation at 50 days p.i. when there was an average serum HI titre of 1/446 but no detectable lung HI antibody (see below), 
Time-course of the production of HI and NI antibody in the serum of infected mice
* At 5 days p.i. lung extracts and sera were tested at a 1/10 dilution. t Neutralization (~) with serum diluted 1/10 compared with virus incubated with 1/10 normal mouse serum. :~ Data from Dimmock et aL (1986) . The mean value is given in parentheses at the end of each column of figures. (Dimmock et al., 1986) . The time-course of serum HI antibody production is shown for comparison in Fig. 2 . There is an initial rapid rise of HI antibody in both groups of mice with a suggestion that the level in those animals receiving WSN and BPL DI virus is declining on day 7 p.i. just before their death (Fig. 2) . Serum HI antibody in the group inoculated with WSN and DI WSN is biphasic, peaking at 9 days p.i. and then declining before it peaks again by day 50. HI antibody in the lung declines and by day 20 p.i. none is detectable (Dimmock et al., 1986) . The time-course of the appearance of neuraminidase antibody in the lung extracts in Fig. 3 shows a parallel rise in both groups of infected mice (Fig. 3 a) whereas HI antibody is seen (in the same extracts) only in mice receiving WSN and DI WSN (Fig. 3b) . Both antibodies reached maximum activity very early at 3 days p.i. (anti-NA) and 5 days p.i. (anti-HA) and both were IgG. Neither DI virus nor BPL DI virus alone stimulated detectable HI or NI activity by day 15 p.i. 
Adoptive transfer of affinity-purified lung HA-specific IgG
Initially, non-purified lung antibody with HI but no neutralizing activity was given to 5-weekold mice of either sex intranasally or intravenously either 24 h before infection with 4 LD50 of WSN or 24 h afterwards. Inoculation of 128 to 160 HIU gave 50~o more survivors in the group (10 mice/group) given the antibody intravenously 24 h before infection than in the control WSNinfected mice. Inoculation after infection had no sparing effect. Administration of lung HI antibody intranasally or lung extract from non-infected mice intransally or intravenously did not alter the course of the disease. The experiment was repeated using higher concentrations of antibody given intravenously at 24 h before infection. Fig. 4 shows that 60~ (6/10) of mice given 800 HIU survived infection. In a repeat experiment 70~ survived (again groups of 10 mice). In the same experiment mice were given extracts from the lungs of mice inoculated with WSN and BPL DI WSN or from non-infected mice; this had no protective activity. The former contains the same level of anti-neuraminidase antibody as mice given WSN and DI WSN but no HI activity.
In another control group, mice were given 800 HIU of a monoclonal IgG to WSN HA which had both HI and neutralizing activity (kindly provided by Dr R. G. Webster). The two antibodies used (189/2 and 523/4) were both IgGl. Both were given 24 h before infection and as expected protected 100~ mice from clinical signs of disease (not shown) and from death (Fig. 4) .
In order to focus on the nature of the protecting activity, HA-specific antibody was affinity purified by adsorption and elution from L cells infected with the vacc-HA recombinant (Stephens et al., 1986) . This purified antibody had HI but no detectable neutralization activity.
When inoculated to mice intravenously 24 h before infection, it conferred protection on the majority (60~) of otherwise lethally infected animals. Gross pathology of the lung was considerably diminished; at 5 days p.i., when control mice had about 50~ or more of lung showing signs of consolidation, lungs of mice passively immunized with non-neutralizing HI antibody were around 10~o consolidated. Titration of lungs for infectious virus showed that there was no difference in multiplication between mice adoptively immunized with the non-neutralizing HI antibody and the infected control group (data not shown). Reduction in lung pathology with no effect on virus multiplication in the lung is characteristic of the protection of lethally infected mice by administration of DI WSN (Dimmock et al., 1986) .
DISCUSSION
The lungs of mice infected with WSN (not shown) or with WSN plus BPL DI WSN or WSN plus D! WSN contain NI antibody but only lungs of mice inoculated with WSN plus DI WSN have HI activity as well. Neither antibody is free in the lung but can be released from clarified lung homogenates by treatment at pH 3 or pH 11-5, or by urea or guanidinium isothiocyanate. This paper demonstrates that the HA-reactive immunoglobulins are of the IgG 1, IgG2a and IgG2b isotypes. Other properties are summarized in Table 3 .
Despite the absence of HI antibody from their lungs, lethally infected mice (WSN or WSN plus BPL DI WSN) synthesize serum antibody which is both HI and neutralizing as do mice inoculated with the non-lethal mixture of WSN plus DI WSN. There was no evidence of transport of serum HI antibody into the lung in either group. These data are in general agreement with those of Hocart et al. (1988) who concluded that the ability of murine IgG subclasses to cross the mucosal surfaces of the respiratory tract is not established. Since all groups of infected mice synthesize HI and NI antibody systemically and contain anti-NA in the lung it seems likely that infection with WSN specifically inhibits HI antibody synthesis in the lung. It should be remembered that the lungs of both groups of infected mice express equal amounts of infectious virus and HA antigen as determined by ELISA (Dimmock et al., 1986) so that a simple difference in the HA immunogen would not seem to be the explanation. Thus there is inferential evidence that WSN immunosuppresses HI but not NI antibody synthesis in the lung and that this suppression is released by coinoculation of mice with DI WSN. This is consistent with a demonstration by Casali et al. (1984) that WSN is selectively immunosuppressire. They showed that WSN inhibited the normal mitogenic response of human lymphocytes to phytohaemagglutinin and the synthesis of IgG in response to pokeweed mitogen but had no effect on the cytotoxic activity of natural killer cells. However, our situation is further complicated by the unusual non-neutralizing nature of the lung HI antibody. It would seem likely that infection of one of the cell types concerned with antibody synthesis (the HA-specific B lymphocyte, T-helper cell or antigen-presenting cell) with WSN prevents its function and that coinfection of this particular cell type with DI WSN releases the block but allows the synthesis of only some of the repertoire of HA antibody specificities. Normally antibody produced in mammals in response to infection or to immunization by influenza virus or viral HA is both HI and neutralizing. However, these two properties do not necessarily go hand-in-hand: antibody against avian (Lu et al., 1982) , mammalian (Kida et al., 1982) or human (Beebe et al., 1983) influenza viruses may have neutralizing but no HI activity. Other monoclonal antibodies bind to HA but have neither HI nor neutralizing activity (Breschkin et al., 1981) . The only report of an influenza virus antibody similar to ours is a monoclonal antibody which was used to prepare escape mutants of A/USSR/90/77 (HINI); this reacted with the mutants by HI but not neutralization (Gitelman et al., 1986) . There is also a monoclonal antibody of this specificity against Newcastle disease virus (Nishikawa et al., 1983) .
Lung HI IgG is also unusual in failing to bind to Protein A. This results from an interaction between Protein A and a site between the C~2 and C73 domains of IgG. All mouse and human IgG isotypes normally bind Protein A. However replacement of arginine for histidine 435 in human IgG3 prevents binding (see review by Burton, 1985) .
Surprisingly the non-neutralizing, HA-specific IgG protected mice against lethal WSN infection when adoptively transferred to immunologically naive mice. One clue to how it does this comes from the finding that both lung extracts and afffinity-purified IgG have the capacity to enhance killing up to sevenfold by cytotoxic T cells obtained from the lungs of mice inoculated with WSN and DI WSN (L. McLain & N. J. Dimmock, unpublished data) . It is possible therefore that non-neutralizing HA-specific IgG exerts its protective effects in vivo by ADCC with lung T cells, or perhaps with other cells (monocytes, macrophages, polymorphonuclear leukocytes, lymphocytes) which carry Fc receptors (Burton, 1985; Lanier & Phillips, 1986; Unkeless et al., 1988) . Another possibility is that the HA-specific lung IgG acts via complement as this neutralized infectivity when added to mixtures of virus plus affinity-purified antibody (data not shown).
Although there is a strong correlation, we cannot conclude that the non-neutralizing HAspecific antibody described above is alone responsible for the protective effects of DI WSN in WSN-infected mice as these animals exhibit other alterations of their immune responses. For instance the lung pathology in mice with an influenza pneumonia is reputedly caused by a delayed-type hypersensitivity response (Leung & Ada, 1980; Ada et al., 1981 ; Liew & Russell, 1980) and this could be directly or indirectly reduced by DI WSN; secondly we have found differences, both quantitative and qualitative, in the cytotoxic T cell response in mice given WSN plus DI WSN compared to those receiving WSN plus BPL DI WSN which may also be important in protection mediated by the DI virus (L. McLain & N. J. Dimmock, unpublished data) .
